King's College London

Research portal

Why should pharmacological trials in schizophrenia employ functional magnetic resonance imaging (fMRI)?

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1158-1160
Number of pages3
JournalJournal of Psychopharmacology
Issue number9
Accepted/In press2021
PublishedSep 2021

Bibliographical note

Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: SS is supported by a European Research Council (ERC) Consolidator Award and by the National Institute for Health Research (NIHR) South London and Maudsley Biomedical Research Centre (BRC). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

King's Authors

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454